Case Report: Four Cases of Panayiotopoulos Syndrome Evolving to Juvenile Myoclonic Epilepsy.

Panayiotopoulos syndrome atypical evolution idiopathic generalized epilepsy juvenile myoclonic epilepsy self-limited focal epilepsy

Journal

Frontiers in neurology
ISSN: 1664-2295
Titre abrégé: Front Neurol
Pays: Switzerland
ID NLM: 101546899

Informations de publication

Date de publication:
2020
Historique:
received: 04 08 2020
accepted: 17 11 2020
entrez: 21 12 2020
pubmed: 22 12 2020
medline: 22 12 2020
Statut: epublish

Résumé

Panayiotopoulos syndrome (PS) is a self-limited focal epilepsy appearing in childhood. Seizures in PS are self-limiting and do not usually continue into adulthood. Juvenile myoclonic epilepsy (JME) is the most common type of idiopathic generalized epilepsy, developing around puberty and continuing throughout adulthood. We describe four cases of PS in childhood in which JME developed in adolescence. Age at onset ranged from 4 to 8 years for PS, and 11 to 14 years for JME. JME developed after PS subsided, with the interval between last PS seizure and first JME seizure ranging from 1 to 10 years. No link between the two conditions has previously been described. Since PS is considered to show good prognosis and to be self-limiting, long-term observation has been considered unnecessary. No definitive factors were found to predict future evolution to JME in our series, so longer-term follow-up may be warranted for all PS patients.

Identifiants

pubmed: 33343495
doi: 10.3389/fneur.2020.591477
pmc: PMC7744758
doi:

Types de publication

Case Reports

Langues

eng

Pagination

591477

Informations de copyright

Copyright © 2020 Enoki, Itamura, Baba, Okanishi and Fujimoto.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Dev Med Child Neurol. 2006 Mar;48(3):236-40
pubmed: 16483404
Epileptic Disord. 2006 Mar;8(1):53-6
pubmed: 16567326
Pediatr Neurol. 2004 Jan;30(1):24-8
pubmed: 14738945
Brain. 2004 Aug;127(Pt 8):1878-86
pubmed: 15201194
Epilepsia. 2007 Jun;48(6):1054-61
pubmed: 17442007
Seizure. 2017 Jul;49:36-41
pubmed: 28544889
Epilepsy Res. 2015 Aug;114:2-12
pubmed: 26088880
Epilepsia. 2017 Apr;58(4):512-521
pubmed: 28276062
Seizure. 2008 Oct;17(7):617-24
pubmed: 18524634
Epilepsia. 2010 Oct;51(10):2098-107
pubmed: 20528983
Epileptic Disord. 2020 Feb 1;22(1):67-72
pubmed: 32020894
Epileptic Disord. 2002 Mar;4(1):35-42
pubmed: 11967178

Auteurs

Hideo Enoki (H)

Comprehensive Epilepsy Center, Seirei Hamamatsu General Hospital, Hamamatsu, Japan.

Shinji Itamura (S)

Comprehensive Epilepsy Center, Seirei Hamamatsu General Hospital, Hamamatsu, Japan.

Shimpei Baba (S)

Comprehensive Epilepsy Center, Seirei Hamamatsu General Hospital, Hamamatsu, Japan.

Tohru Okanishi (T)

Comprehensive Epilepsy Center, Seirei Hamamatsu General Hospital, Hamamatsu, Japan.

Ayataka Fujimoto (A)

Comprehensive Epilepsy Center, Seirei Hamamatsu General Hospital, Hamamatsu, Japan.

Classifications MeSH